Author:
Pavlova G. V.,Baklaushev V. P.,Ivanova M. A.,Goriaĭnov S. A.,Rybalkina E. Iu.,Kopylov A. M.,Chekhonin V. P.,Potapov A. A.,Konovalov A. N.
Publisher
Media Sphere Publishing Group
Reference145 articles.
1. Kobyakov G.L. Khimioterapiya v kompleksnom lechenii bol'nykh s pervichnymi zlokachestvennymi opukholyami golovnogo mozga: Avtoref. dis. ... d-ra med. nauk. M 2012.
2. Crocetti E., Trama A., Stiller C. et al., RARECARE working group. Epidemiology of glial and non-glial brain tumours in Europe. Eur J Cancer 2012; 48: 10: 1532-1542.
3. Stupp R., Hegi M.E., Mason W.P. et al. European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups; National Institute of Canada Clinical Trials Group. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised Phase III study: 5-year analysis of the EORTCNCIC trial. Lancet Oncol 2009; 10: 5: 459-466.
4. Chekhonin V.P., Baklaushev V.P., Yusubalieva G.M., Belorusova A.E., Gulyaev M.V., Tsitrin E.B., Grinenko N.F., Gurina O.I., Pirogov Y.A. Targeted delivery of liposomal nanocontainers to the peritumoral zone of glioma by means of monoclonal antibodies against GFAP and the extracellular loop of Cx43. Nanomedicine 2012; 8: 1: 63-70.
5. Biswas S., Torchilin V.P. Nanopreparations for organelle-specific delivery in cancer. Adv Drug Deliv Rev 2013. pii: S0169-409X(13)00263-9.